Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Edwards receives CE mark for transfemoral mitral valve replacement system
, /in Cardiology, Product News /by panglobalEdwards Lifesciences has obtained European regulatory approval for its SAPIEN M3 system, making it the world’s first transcatheter mitral valve replacement therapy delivered via a transfemoral approach for treating mitral regurgitation.
Womed introduces first intrauterine adhesion barrier film to European market
, /in Product News, Women's Health /by panglobalWomed has launched its pioneering medical device designed to prevent intrauterine adhesions (IUA) across 14 European countries through new distribution partnerships with Kebomed Europe and Saesco Medical.
Philips receives EU MDR certification for remote scanning solution
, /in MedTech, Product News /by panglobalPhilips has announced that its Radiology Operations Command Center Console has received EU Medical Device Regulation (MDR) certification for remote scanning capability, enabling expert radiologists to remotely control scans and assist technologists in real-time across multiple locations in Europe.
Baxter introduces room temperature Hemopatch for surgical bleeding control
, /in Product News, Surgery /by panglobalBaxter International Inc. has announced the European launch of its Hemopatch Sealing Hemostat with room temperature storage capability, eliminating the need for refrigeration and enabling immediate accessibility in operating theatres.
AI tool for NASH diagnosis receives first EMA qualification
AIM NASH, /in Diagnostic tests, E-News, Product News /by panglobalThe European Medicines Agency has qualified the first artificial intelligence-based tool designed to evaluate liver biopsies in patients with metabolic dysfunction-associated steatohepatitis (MASH). The system, called AIM-NASH, helps pathologists assess disease severity and reduce variability in histological scoring, with the aim of accelerating drug development for this increasingly common liver condition.
Glutamate-triggered liver regeneration mechanism discovered
glutamate, liver, /in E-News, Regenerative Medicine /by panglobalNew research reveals a rapid regenerative pathway activated minutes after liver injury through glutamate signalling between liver and bone marrow, offering potential therapeutic applications for liver damage.
Beckman Coulter introduces ground-breaking next-gen basophil activation test for allergy research
allergy, /in Product News /by panglobalBeckman Coulter Life Sciences has launched a ground-breaking Next-Generation Basophil Activation Test (BAT) that could transform food allergy research by eliminating the need for potentially dangerous allergen exposure.
Major cancer prevention report analyses world’s largest evidence base on dietary patterns
diet, /in E-News, Oncology /by panglobalA major new report by World Cancer Research Fund International provides strong evidence that following specific dietary and lifestyle patterns can significantly reduce cancer risk. The report, released 9 April, reviews 170 global studies and presents comprehensive recommendations based on patterns of eating, physical activity, and weight management rather than focusing on individual nutrients or […]
Novel gene therapy restores vision in mice by preventing Prox1 protein transfer
retina, /in E-News, Regenerative Medicine /by panglobalKorean researchers have developed a breakthrough gene therapy that restores vision loss caused by retinal degeneration. The therapy works by neutralising a protein called Prox1 that suppresses retinal regeneration. When the Prox1 protein is blocked, Müller glial cells in the retina can reprogram into stem-like cells that regenerate damaged neurons, restoring visual function.
Cystic Fibrosis Foundation invests in Owlstone to develop breath test for Pseudomonas detection
, /in Diagnostic tests, E-News /by panglobalThe Cystic Fibrosis Foundation has committed up to US$2.3 million (about £1.7 million) in equity investment to Owlstone Medical for the development of a breath test to detect Pseudomonas aeruginosa (PA) infections in people with cystic fibrosis (CF). The Cambridge-based company announced the investment on March 25, 2025, marking a significant step forward in respiratory […]